News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Personnel
Taro (TARO) Announces Appointment Of Interim CEO 12/2/2016
Innovative Medicines Canada Welcomes Pamela Fralick As New President 12/2/2016
MeriCal Names Jeremy Bartos, Ph.D., As Director Of Sales And Product Development 12/2/2016
Leading Sarcoma Expert Dr. Earl W. Brien Joins CytRx (CYTR) Board Of Directors 12/2/2016
Floundering SoCal Biotech Arrowhead Pharma (ARWR) Fires CSO, Effective Later This Month 12/2/2016
Theranos Cleans House, Gets Rid of Some High-Profile Board Members 12/2/2016
Renowned Scientist Joins Nutrition Research Institute 12/2/2016
bluebird bio (BLUE) Announces Management Appointments 12/2/2016
Gino DeSimone Named Senior Vice President For Sales And Marketing At Rodo Medical 12/2/2016
New Boston Biotech Axial Biotherapeutics Launches With $19.15 Million and Will be Helmed by AbbVie (ABBV)-GlaxoSmithKline (GSK) Vet 12/1/2016
What The...?! It’s Trump! 12/1/2016
Arquer Diagnostics Taps a New CEO 12/1/2016
Siemens (SI)'s U.S. CEO to Step Down by End of Year, New Leader Named 12/1/2016
Codexis, Inc. (CDXS) Names Pharmaceutical Industry Veteran Bernard J. Kelley Chairman Of The Board 12/1/2016
Otonomy (OTIC) Appoints Kathie M. Bishop, Ph.D., as Chief Scientific Officer 12/1/2016
Nanotherapeutics Appoints Prasad Raje, Ph.D. As President And Chief Executive Officer 12/1/2016
Oncodesign SA Completes The Acquisition Of François Hyafil Research Centre And Appoints Two New Strategic Activity Directors 12/1/2016
Aimmune (AIMT) Appoints Scientific Advisory Board Of World-Renowned Food Allergy Experts 12/1/2016
SciBase AB Appoints Anna Danström As New Head Of Production And Supply Chain 12/1/2016
Kite Pharma (KITE) Appoints Jian Irish, Phd As Senior Vice President Of Supply Chain 12/1/2016
Sangamo (SGMO) Makes Key Leadership Appointments To Strengthen Clinical And Commercial Capabilities 12/1/2016
Rebecca Jolley Appointed Senior Vice President Americas Commercial, Oncology Business Group At Eisai Inc. (ESALF.PK) 12/1/2016
Akashi Appoints Alka Batycky To Executive Vice-President, Portfolio Management And Operations 12/1/2016
Four Promoted At SCORR Marketing 12/1/2016
ACI Clinical Expands Leadership Team To Support Growth 11/30/2016
CytRx (CYTR) Plans to File NDA for Once-Failed Sarcoma Drug While Columnist Raises Questions Over Efficacy and CEO Salary Amid Struggle 11/30/2016
GenomOncology Names Joshua F. Coleman, M.D. As New VP Of Medical Affairs 11/30/2016
Mats Wahlström Joins Surefire Board Of Directors 11/30/2016
TxCell Completes Aligning Operations With Strategic Refocus 11/30/2016
Champions Oncology, Inc. (CSBR) Reports 50% Revenue Growth, Accelerated Progress On Path To Profitability And Future Role Changes Of The Senior Leadership 11/30/2016
Valeant (VRX) Announces The Initiation Of A Primary Care Sales Force For Xifaxan And Relistor 11/30/2016
David Epstein Joins As Special Advisor To Remedy Pharmaceuticals, Inc. 11/30/2016
World Renowned Experts Join Variant Pharma Scientific Advisory Board 11/30/2016
President-Elect Trump Set to Debut Dream Team for Healthcare Reform 11/29/2016
Invacare (IVC) Appoints Susan Alexander To Board Of Directors 11/29/2016
ViraCyte Appoints Dr. Brett Giroir As President and Chief Executive Officer 11/29/2016
Eyenovia Announces Publication Of Phase II Study Results Demonstrating Benefits Of Micro-Formulation Over Conventional Eyedroppers And Addition Of Scientific Advisory Board Members 11/29/2016
KalVista Pharmaceuticals Appoints Edward P. Feener, Ph.D. As Chief Scientific Officer 11/29/2016
Salk Institute for Biological Studies Names Ted Waitt Board Chairman 11/29/2016
Cornerstone Pharmaceuticals, Inc. Appoints Brian Mullaney, M.D., Ph.D., As Chief Medical Officer 11/29/2016
Jill Hagenkord MD Joins MIODx Board Of Directors 11/29/2016
Albireo (ALBO) Expands Team, Appoints Martha J. Carter As Chief Regulatory Officer 11/29/2016
Actinium (ATNM.OB) Further Strengthens Clinical Development Team With Senior Hire To Support Later-Stage Clinical Trials 11/29/2016
C3 Jian Announces Corporate Name Change And Expansion Of Management Team 11/29/2016
AVANIR (AVNR) Appoints Richard Malamut, MD, As Senior Vice President, Research & Development, And Chief Medical Officer 11/29/2016
Veteran Regulatory Expert Maria Chan Joins Personal Genome Diagnostics 11/29/2016
Aptuit Names Peter Gray As The New Chairman Of Aptuit Holdings, LLC 11/29/2016
Dr. David Tuveson Named Director, NCI-Designated Cancer Center At Cold Spring Harbor Laboratory 11/29/2016
miRagen Expands Executive Leadership Team 11/29/2016
Entasis Names Greg Norden, Former Senior Vice President And Chief Financial Officer Of Wyeth (WYE), To Its Board Of Directors 11/29/2016
CogState Ltd (CGS.AX) Announces New Executive Appointments For Clinical Trials And Healthcare Business Units 11/29/2016
How Donald Trump Could Disrupt the FDA 11/28/2016
'Retired' Former Novartis AG (NVS) R&D Cancer Head Returns for a New Gig at the Dana-Farber Cancer Institute 11/28/2016
Synthorx Appoints Patrick J. Doyle As Chief Business Officer 11/28/2016
French Cancer Specialist Innate Pharma (IPH.PA ) Can Remain Independent, For Now: CEO 11/28/2016
Cascadian Therapeutics (ONTY) Strengthens Management Team With Key Hires, Monique M. Greer And Marc C. Chamberlain, M.D. 11/28/2016
IMPAX Labs (IPXL) Announces Appointment Of J. Kevin Buchi To Board Of Directors 11/28/2016
Rebiotix Appoints Ken F. Blount, Ph.D., Head Of External Research 11/28/2016
Addex Therapeutics (ADXN.SW) Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., As Chief Medical Officer 11/28/2016
MediCannaVision Inc., A Stereovision Wholly Owned Medical Cannabis And Hemp Florida C Corp Seats Board Of Directors 11/28/2016
This Could be The Reason Elizabeth Holmes is Still Leading Theranos 11/23/2016
Incoming Regenstrief Institute President Embi Named Chair-Elect Of AMIA Board Of Directors 11/23/2016
Oncoceutics Promotes Lee Schalop, MD, To Chief Operating Officer 11/23/2016
Medifirst Solutions Appoints Bill White To Its Advisory Board 11/23/2016
Groundbreaking Team At Aquinnah Pharmaceuticals Adds Two New Members To Help Overcome The Challenge Of ALS And Alzheimer's Disease 11/22/2016
Pernix (PTX) Appoints New Board Member 11/22/2016
Paragon Bioservices Appoints John Conner As SVP GMP Manufacturing 11/22/2016
Select Medical (SLMC) Names Scott Nordlund To Lead Partnership Growth And Innovation 11/22/2016
Taro (TARO) Taps Sun Pharma (SUNPHARMA.NS) CFO as New CEO 11/22/2016
C4X Discovery Release: Board Changes 11/22/2016
MediGene AG (MDGEF.PK) Appoints Dr. Thomas Taapken As Chief Financial Officer 11/22/2016
Cell MedX Corp Appoints Gregory Pek To The Advisory Board And As A Distributor 11/22/2016
Collagen Matrix, Inc. Names Oystein Valberg As Chief Financial Officer 11/22/2016
SciBase AB Strengthens Its Management Team With Niklas Jakobsson 11/22/2016
Zymeworks Announces The Addition Of Lota S. Zoth To Its Board Of Directors 11/22/2016
Xenetic Biosciences Appoints Edward J. Benz, Jr., M.D., Former Dana-Farber Cancer Institute CEO, To Its Board Of Directors 11/22/2016
Enanta Pharmaceuticals, Inc. Announces The Appointment Of Dr. Lesley Russell To Its Board Of Directors 11/22/2016
CEO Roundtable On Cancer Names Joaquin Duato To Board Of Directors 11/22/2016
Zensights Names Will Passano President 11/22/2016
Embattled GlobeImmune (GBIM) Loses Gilead (GILD) Deal, Cancels HQ Lease, and CEO Resigns 11/21/2016
Zensights Names Will Passano President 11/21/2016
Veracyte (VCYT) Appoints Keith Kennedy As Chief Financial Officer 11/21/2016
ETST Announces 60-Patient Clinical Prelaunch Study For Its MSN-2 Medical Device For The Diagnosis Of Chlamydia & Gonorrhea, ETST Elects Dr. Michel Aubé As New CEO & CSO, And Nickolas Tabraue As President 11/21/2016
Lexicon Pharma (LXRX) Announces The Establishment Of The Commercial Leadership Team For Telotristat Ethyl 11/21/2016
William J. Link, PhD, Joins Allegro Ophthalmics LLC’ Board Of Directors 11/21/2016
Gamida Cell Names Julian Adams, Ph.D. New Chairman Of The Board 11/21/2016
Scientific Expert, Dr. Roger Esteban-Vives, Joins Renovacare To Advance Its Skinguntm Technology For Spraying Stem Cells Onto Burns 11/21/2016
Buck Institute for Age Research Announces New CEO And $10 Million In Gifts To Fuel Growth 11/21/2016
AGTC (AGTC) Appoints Michael Goldstein, M.D. As Chief Medical Officer 11/18/2016
Delaware BioScience Association Announces New President 11/18/2016
Evolve BioSystems Welcomes Susan Vandegrift As New Chief Financial Officer 11/18/2016
Paragon Bioservices Appoints Ruby Hofmann As VP Of Human Resources And Organizational Development 11/18/2016
Royal Society Of Medicine Appoints Helen Gordon As New Chief Executive 11/18/2016
Delivra CFO Resigns, Effectively Immediately 11/18/2016
Management Team Strengthened As Auspherix Drives New Class Of Antibacterials Towards The Clinic 11/17/2016
Ryan Chavez Appointed Chief Financial Officer Of Asterias Biotherapeutics 11/17/2016
Virtual Biotech Syntimmune Taps Boehringer Ingelheim-Pfizer (PFE) Alum as New CEO and Rakes in Some More Cash to Bring Drugs Into Clinic 11/17/2016
C4 Therapeutics Announces World-Class Scientific Advisory Board With Expertise In Therapeutics And The Ubiquitin-Proteasome System 11/17/2016
Gilead (GILD) Announces Promotion Of James R. Meyers To Executive Vice President, Worldwide Commercial Operations 11/17/2016
C4 Therapeutics Announces World-Class Scientific Advisory Board With Expertise In Therapeutics And The Ubiquitin-Proteasome System 11/17/2016
Calimmune Appoints Salim Yazji, M.D. As Executive Vice President And Chief Medical Officer 11/17/2016
Gilead (GILD) Announces Promotion Of James R. Meyers To Executive Vice President, Worldwide Commercial Operations 11/17/2016
SELLAS Life Sciences Group Welcomes Internationally Renowned Experts In Immuno-Oncology To Scientific Advisory Board 11/17/2016
Top 10 Amgen (AMGN) Scholars to Watch Set to Impact the Future of Science and Medicine 11/16/2016
Led by Former Eli Lilly (LLY) Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/2016
IDEXX Laboratories (IDXX) Announces Departure Of Executive Vice President Michael Williams 11/16/2016
PharmaMar Appoints Pascal Besman As Chief Operating Officer Of PharmaMar U.S. 11/16/2016
Nuvo Pharma Appoints Jesse Ledger As President 11/16/2016
Atrin Pharmaceuticals Elects Jeffrey M. Dayno, MD To Board Of Directors 11/16/2016
Penumbra Announces Resignation Of Board Member 11/16/2016
Quanta Aesthetic Lasers Promotes Michael Sparks to CEO 11/16/2016
Myovant Appoints Terrie Curran To Board Of Directors 11/16/2016
Achaogen (AKAO) Adds Gary Loeb As General Counsel 11/16/2016
Dr. Steve Myers Named Chief Medical Officer At Cocoon Biotech 11/16/2016
Global CRO Pharm-Olam International Ltd. Announces New Addition To The Quality And Compliance Leadership Team 11/16/2016
Cogmedix Welcomes New VP Of Engineering 11/16/2016
Jubilant DraxImage Appoints James Kaufman As Director Marketing, PET Products 11/16/2016
Celgene (CELG) Exec Out as Trump Puts Vice President Elect Leader of Transition Effort 11/16/2016
5 Biopharma Influencers Likely to Be on Trump’s Transition Team 11/16/2016
Biogen (BIIB) Taps Former Spark Therapeutics (ONCE) Exec and a Finance Vet for Hemophilia Spin-off Company Bioverativ 11/15/2016
Orthobond Appoints New CEO and New President and COO 11/15/2016
Blueprint Medicines (BPMC) Announces Appointment Of Marion Dorsch, Ph.D. As Chief Scientific Officer And The Transition of Christoph Lengauer, Ph.D., MBA, To A Newly Created Executive Vice President Role 11/15/2016
Vermillion Announces Appointment of Chief Medical Officer 11/15/2016
Dragonfly Adds Expert In Protein Engineering And Structure To Its Scientific Advisory Board 11/15/2016
Acesion Pharma Recruits An Experienced Life Science Chief Financial Officer 11/15/2016
Nordic Nanovector Appoints Lisa Rojkjaer, MD As Chief Medical Officer 11/15/2016
Health Care Business Development Executive Joins SCORR Marketing 11/15/2016
Rigontec GmbH Appoints Dr. Jörg Vollmer As Chief Scientific Officer 11/15/2016
MEDIAN Technologies Appoints Jeanne Hecht As Chief Operating Officer And Nicholas Campbell As Chief Commercial Officer 11/15/2016
Meet the Woman That's Helming Bay Area's Calithera Biosciences (CALA) 11/14/2016
Integrity Applications Incorporated Release: GlucoTrack Maker Names Two New Board Members 11/14/2016
MMJ PhytoTech Appoints Lead Manager For TSX-V Capital Raising 11/14/2016
IDEXX Laboratories (IDXX) Welcomes Healthcare Technology Veteran Pat Venters As Chief Marketing Officer 11/14/2016
Adriane M. Brown To Join Allergan (AGN) Board Of Directors 11/14/2016
Tech Council of Maryland Announces Chairman And New Board Members 11/14/2016
Titan Spine Appoints Spine Industry Veteran Ted Bird As Chief Commercial Officer 11/14/2016
Cipher Pharma (DND.TO) Announces Management Change 11/11/2016
Perrigo (PRGO) Announces Appointment Of Two New Independent Directors To Board 11/11/2016
Lycera Announces Appointments Of Leading Experts To Scientific Advisory Board 11/11/2016
Akriveia Therapeutics Announces Key Additions To Its Leadership Team 11/11/2016
Celgene (CELG) Exec May be a Dark Horse Candidate for Donald Trump's Secretary of Health and Human Services 11/11/2016
Trump Promises to "Reform the FDA" in Post-Election Mission Statement 11/11/2016
Sofregen Medical Bolsters Leadership Team And Board 11/10/2016
Medtech Startup Forus Forms First U.S. Subsidiary in the Bay Area, Brings Aboard Two Former Johnson & Johnson (JNJ) Execs 11/10/2016
Martin Shkreli Makes Good On Promise, Shares Secret Wu-Tang Clan Songs After Trump Win 11/10/2016
Fibrocell (FCSC) Appoints Alfred T. Lane, MD, Chief Medical Advisor 11/10/2016
Crinetics Appoints Anne Klibanski, M.D. To Scientific Advisory Board 11/10/2016
WAVE Life Sciences (WVE) Appoints Christian Henry To Its Board Of Directors 11/10/2016
Oncolytics Biotech Inc. (ONC.TO) Announces Appointment Of New Chief Medical Officer 11/10/2016
CytRx (CYTR) Reports Third Quarter 2016 Financial Results 11/10/2016
DisperSol Names Dr. Edward M. Rudnic As Chief Executive Officer, RCT Leads $12 Million Funding Round 11/9/2016
AVROBIO Expands Senior Management Team With Three Key Hires 11/9/2016
Frazier Healthcare Partners Expands Growth Buyout Investment Team 11/9/2016
Genos Biosciences Reveals Strategic Advisory Board Comprised Of Industry Luminaries In Genetics, Economics, And Consumer Technology 11/9/2016
Hansa Medical's Nomination Committee For The AGM 2017 Appointed 11/9/2016
EXACT Sciences (EXAS) Appoints Jeff Elliott Chief Financial Officer 11/9/2016
Eutilex Names Agustin de la Calle Chief Business Officer 11/8/2016
Harpoon Therapeutics Appoints Hans-Peter Gerber, PhD, as Chief Scientific Officer 11/8/2016
Pernix (PTX) Appoints Two Board Members 11/8/2016
Anke Linnartz Joins MorphoSys USA, Inc. As Head Of Corporate Communications And Investor Relations 11/8/2016
PSR Orphan Experts Launches Patient Organization Advisory Board 11/8/2016
vasopharm Appoints Chief Medical Officer 11/8/2016
NeuroMetrix (NURO) Announces Promotion Of Frank Mcgillin To Chief Commercial Officer 11/8/2016
Bone Therapeutics Taps a New CEO, Drops Plan to Initiate Cell Therapy Trial in the U.S. 11/8/2016
Teva (TEVA) Announces Appointment Of New Chief Legal Officer 11/8/2016
Changes In The AYOXXA Biosystems GmbH Management Team 11/7/2016
Fortress Biotech (CNDO) Forms Cellvation, Taps Forest (FRX), Life Technologies (LIFE) Alum as Interim CEO 11/7/2016
Amgen (AMGN)'s Dr. Joshua Ofman Elected Chairman Of National Pharmaceutical Council's Board Of Directors 11/7/2016
Shield Therapeutics Board Change 11/7/2016
Bioventus Appoints Andrew Mccartney Managing Director, International For EMEA 11/7/2016
Veristat Appoints James Roach, M.D. As Chief Medical Officer 11/7/2016
Neon Therapeutics Appoints Dr. Richard Gaynor To President Of Research And Development 11/7/2016
Genprex Expands Executive Management Team And Completes Funding 11/7/2016
Enyo Pharma Strengthens Its Management Team To Support Its Strategy Of International Growth 11/7/2016
Semma Therapeutics Announces Mark Fishman, M.D. Has Joined Its Board Of Directors As Chairman 11/7/2016
Adare Pharma Appoints Dr. Peter Richardson As Vice President, Research & Development And Chief Medical Officer 11/7/2016
Endo International (ENDP) Strengthens Leadership Team With Appointment Of Two Key Executives 11/7/2016
InnaVirVax Strengthens U.S. Management And Presence 11/4/2016
Beaver-Visitec International Names Dana G. Mead Jr. President And CEO 11/4/2016
TherapeuticsMD (TXMD) Expands Commercial And Business Development Leadership 11/4/2016
Central Europe Genomics Center (CEGC) Engages Agent Alan Morell As Senior Advisor; Presented A 10 Figure Plus Term Sheet For Whole Genome Sequencing Servicing 500 Billion R&D Market Of Central Europe 11/4/2016
Merus (MRUS) Strengthens Executive Management Team With The Appointment Of John Crowley As Chief Financial Officer 11/3/2016
Therapix' Board Of Directors Is Joined By Stephen M. Simes 11/3/2016
Phagelux Announces The Addition Of Dr. Rong Chen As Global CMO 11/3/2016
CompuMed (CMPD) Announces Changes In Board Of Directors 11/3/2016
Quotient Limited (QTNTU) Announces CFO Transition 11/3/2016
Allakos Appoints Steven P. James To Board Of Directors 11/3/2016
Enterome Appoints Christophe Bonny As Chief Scientific Officer 11/3/2016
Xenikos Appoints Eric Van Hooren As Chief Development Officer To Drive Forward T-Guardtm Clinical Development Program 11/2/2016
Enzyvant Sciences Appoints Dr. Alvin Shih As Chief Executive Officer 11/2/2016
Flex Appoints Dr. Kal Patel As Senior Vice President Of Digital Health 11/2/2016
Amgen (AMGN) Appoints Lori Johnston As Senior Vice President, Human Resources 11/2/2016
MaxCyte, Inc. Appoints Executive Vice President, Business And Strategic Development 11/2/2016
Tocagen Strengthens Leadership Team: Martin Duvall Appointed As Chief Executive Officer 11/2/2016
Concordia (CXR.TO) Announces New Leadership Appointments 11/2/2016
Momenta (MNTA) Appoints Scott M. Storer As Senior Vice President And Chief Financial Officer 11/2/2016
Savara Appoints David L. Lowrance As CFO 11/2/2016
Arcadia Biosciences (RKDA) Adds Kevin Comcowich To Its Board Of Directors 11/2/2016
InVivo Therapeutics (NVIV) Announces Appointment Of Jeffrey Hatfield To Board Of Directors 11/2/2016
Castle Creek Pharma Continues To Build Executive Team As Company Secures Funding, Positive Phase 2 Results 11/2/2016